Dementia drugs, particularly for Alzheimer's Disease, focus on symptom management rather than cure. Cholinesterase inhibitors like donepezil, rivastigmine, and galantamine enhance brain function by boosting acetylcholine levels, crucial for memory and learning. Another medication, memantine, an NMDA receptor antagonist, helps regulate glutamate activity, addressing symptoms such as confusion and memory loss. While these drugs can temporarily improve cognitive function and quality of life, they do not stop the progression of the disease. Ongoing research seeks to identify new therapeutic targets and more effective treatments that could potentially alter the course of dementia in the future.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China